Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. (Q54609134)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. |
scientific article |
Statements
Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. (English)
Michel M van den Heuvel
Wilma Uyterlinde
Andrew D Vincent
Jeroen de Jong
Joachim Aerts
Frederike Koppe
Joost Knegjens
Henk Codrington
Peter W E Kunst
Edith Dieleman
Marcel Verheij
José Belderbos
11 November 2013
110
1
126-131